Home > EMCDDA update on the implications of COVID-19 for people who use drugs (PWUD) and drug service providers.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2020) EMCDDA update on the implications of COVID-19 for people who use drugs (PWUD) and drug service providers. Lisbon: EMCDDA. 6 p.

[img]
Preview
PDF (EMCDDA update on the implications of COVID-19)
853kB

URL: http://www.emcdda.europa.eu/topics/covid-19

COVID-19 is a major global health threat. People who use drugs face the same risks as those of the general population and therefore need to be aware of the appropriate advice to reduce their risk of infection. They can be exposed to additional risks, however, that require developing assessment and mitigation strategies. These are linked to some of the behaviours associated with drug use and to the settings in which drug use take place, or where care is provided. Risks are increased by the high level of physical and psychological comorbidity found among some people who use drugs, the fact that drug problems are often more common in marginalised communities, and the stigmatisation that people who use drugs often experience.


Item Type:Evidence resource
Drug Type:Alcohol or other drugs in general
Intervention Type:AOD disorder harm reduction
Source:EMCDDA
Date:26 March 2020
Pages:6 p.
Publisher:EMCDDA
Corporate Creators:European Monitoring Centre for Drugs and Drug Addiction
Place of Publication:Lisbon
EndNote:View
Related URLs:
Subjects:G Health and disease > Disorder by cause > Communicable disease > Viral disease
J Health care, prevention and rehabilitation > Substance use prevention > Substance use harm reduction
J Health care, prevention and rehabilitation > Health related prevention > Health information and education > Communicable disease control
VA Geographic area > Europe

Repository Staff Only: item control page